Xanthine derivatives as adenosine A1 receptor antagonists
US5840729A · kind A · utility
1Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 1995 |
| Grant date | Nov 24, 1998 |
| Priority date | — |
| Expiry date | Dec 18, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of attenuating a cognitive deficit in a patient in need thereof comprising administering to the patient a xanthine derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.